These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4119442)

  • 1. [Effect of disinfectants on toxoplasma cysts].
    Exner G; Wachtel D; Schweizer H
    Dtsch Gesundheitsw; 1972 Nov; 27(46):2198-200. PubMed ID: 4119442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the activity of the sulphamethoxypyrazine (Longum equals Kelfizina) with pyrimethamine (Daraprim) on the cysts development phase of Toxoplasma gondii in Mastomys natalensis. Further contribution to experimental chemotherapy of toxoplasmosis (author's transl)].
    Werner H; Egger I
    Zentralbl Bakteriol Orig A; 1974 Jun; 226(4):554-60. PubMed ID: 4152678
    [No Abstract]   [Full Text] [Related]  

  • 3. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine.
    Mateus-Pinilla NE; Dubey JP; Choromanski L; Weigel RM
    J Parasitol; 1999 Oct; 85(5):855-60. PubMed ID: 10577720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of two aldehyde-based disinfectants on the infectivity of faecal cryptosporidia for mice.
    Angus KW; Sherwood D; Hutchison G; Campbell I
    Res Vet Sci; 1982 Nov; 33(3):379-81. PubMed ID: 6218554
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disinfectants against Toxoplasma gondii].
    Wachtel D; Mücke H; Sprössig M
    Dtsch Gesundheitsw; 1969 Aug; 24(33):1571-4. PubMed ID: 5376215
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the pathogenicity of Toxoplasma for mice.
    Pellérdy L; Dobos-Kovács M
    Acta Vet Acad Sci Hung; 1974; 24(3):313-26. PubMed ID: 4456996
    [No Abstract]   [Full Text] [Related]  

  • 8. [Possibilities of disinfection in coccidiosis (Eimeria, Isospora, Toxoplasma, and Sarcocystis)].
    Barutzki D; Erber M; Boch J
    Berl Munch Tierarztl Wochenschr; 1981 Nov; 94(22):451-5. PubMed ID: 6802128
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse pathogenicity of Toxoplasma gondii isolated from a goat.
    Dubey JP
    Am J Vet Res; 1980 Mar; 41(3):427-9. PubMed ID: 7369619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ozone and ultraviolet radiation treatments on the infectivity of Toxoplasma gondii oocysts.
    Dumètre A; Le Bras C; Baffet M; Meneceur P; Dubey JP; Derouin F; Duguet JP; Joyeux M; Moulin L
    Vet Parasitol; 2008 May; 153(3-4):209-13. PubMed ID: 18355965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of Toxoplasma gondii, RH strain, in infected mice as determined by the fluorescent antibody technique and the histopathology of toxoplasmosis.
    Ito S; Tsunoda K; Suzuki K
    Natl Inst Anim Health Q (Tokyo); 1967; 7(4):208-20. PubMed ID: 4870980
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.
    Dimier-Poisson I; Aline F; Bout D; Mévélec MN
    Vaccine; 2006 Mar; 24(10):1705-9. PubMed ID: 16256251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of cialit and tego 51 as disinfectant on trophozoites of Toxoplasma gondii].
    Baumgarten HJ
    Dtsch Tierarztl Wochenschr (1946); 1968 Dec; 75(23):598-600. PubMed ID: 5707001
    [No Abstract]   [Full Text] [Related]  

  • 14. An investigation of sterile immunity against toxoplasmosis in rats.
    Freyre A; Falcón J; Mendez J; Correa O; Morgades D; Rodríguez A
    Exp Parasitol; 2004; 107(1-2):14-9. PubMed ID: 15208033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H
    Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strain of mouse highly susceptible to Toxoplasma.
    Kamei K; Sato K; Tsunematsu Y
    J Parasitol; 1976 Oct; 62(5):714. PubMed ID: 978359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of white rat macrophages against Toxoplasma gondii in vitro].
    Chinchilla M; Guerrero OM; Solano E
    Rev Latinoam Microbiol; 1981; 23(4):239-43. PubMed ID: 7348321
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytochemical and biological findings suggested by the PAS reaction in experimental toxoplasmosis in the mouse].
    Mira Gutierrez J; Del Rey Calero J
    Med Trop (Madr); 1966; 42(4):220-31. PubMed ID: 4170610
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxoplasma gondii: differential protection rates by two strains against cyst formation in a rat model.
    Freyre A; Falcón J; Mendez J; González M
    Exp Parasitol; 2006 Dec; 114(4):265-70. PubMed ID: 16709408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunization trials in mice against Toxoplasma gondii using attenuated oocysts].
    Leier H; Boch J; Erber M
    Berl Munch Tierarztl Wochenschr; 1982 Apr; 95(8):151-4. PubMed ID: 7103918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.